MMP9 rs17576: What Your Genotype Means
rs17576 is a missense coding single nucleotide polymorphism located in the MMP9 gene, commonly resulting in an arginine-to-glutamine amino acid substitution (R279Q). This change alters the enzymatic activity of matrix metalloproteinase-9, influencing extracellular matrix degradation, collagen breakdown, and tissue remodeling after ultraviolet photo-exposure. Scientific evidence connecting this variant to specific health and skin traits remains limited and exploratory, reflecting subtle statistical associations rather than deterministic outcomes.
What each genotype means
Typical MMP-9 activity
You carry two copies of the common A allele, which encodes the arginine form of matrix metalloproteinase-9 (R279). Research suggests this baseline genotype maintains typical enzymatic collagen degradation and standard baseline tissue remodeling responses. Because scientific evidence linking this variant alone to substantial clinical differences remains limited and mixed across populations, your overall skin aging and cardiovascular risk profile are predominantly shaped by lifestyle and environmental exposures.
Carried by approximately 60% to 70% of individuals of European and East Asian descent, making it the most frequent genotype globally.
Intermediate MMP-9 activity
You carry one copy of the A allele and one copy of the G allele, resulting in a mixture of arginine and glutamine variants at position 279 of the MMP-9 enzyme. Experimental studies indicate subtle differences in substrate cleavage and extracellular matrix turnover, including collagen breakdown upon UV light exposure, though clinical manifestations are modest. Current published evidence shows inconsistent clinical associations across various traits, meaning this single genotype has limited individual predictive value.
Carried by approximately 25% to 35% of people across European and Asian populations.
Altered MMP-9 activity
You carry two copies of the G allele, which encodes the 279Q form of the MMP-9 enzyme. Some laboratory studies indicate this substitution may influence matrix metalloproteinase-9 enzymatic efficiency, with potential modest effects on collagen processing and solar elastosis following UV exposure. However, associations with overt vascular or inflammatory conditions remain limited and conflicting in published research, so this genotype does not indicate a definitive clinical outcome.
Carried by roughly 2% to 6% of individuals of European and East Asian ancestry, though frequency varies regionally.
What Is rs17576 and Where Is It Located?
The single nucleotide polymorphism rs17576 is a well-studied genetic variant located on chromosome 20 within the coding region of the matrix metallopeptidase 9 (MMP9) gene. At the molecular sequence level, it involves an exchange between adenine (A) and guanine (G) nucleotides. This specific transition changes a single amino acid in the catalytic domain of the resulting protein, replacing arginine with glutamine at position 279, a change frequently denoted in biochemical literature as R279Q. Because it alters the primary amino acid sequence of the enzyme, rs17576 is categorized as a non-synonymous or missense coding variant. Researchers monitor this variant because changes within the protein's catalytic core can directly modify its substrate affinity and enzymatic turnover rate. Despite this biochemical impact, carrying one or two copies of a particular allele at rs17576 is not known to cause monogenic disease, functioning instead as a common source of natural human variation across global populations.
The Biological Role of the MMP9 Enzyme
The MMP9 gene provides instructions for producing matrix metalloproteinase-9, also widely referred to as gelatinase B or 92 kDa type IV collagenase. This zinc-dependent endopeptidase specializes in degrading components of the extracellular matrix, including type IV and type V collagens, gelatin, and elastin. Extracellular matrix remodeling is fundamental to tissue repair, wound healing, vascular maintenance, and immune cell migration. In healthy skin, MMP9 expression is tightly controlled, but it can be rapidly induced by inflammatory signals and environmental stressors such as ultraviolet (UV) radiation. Once activated, MMP9 breaks down structural scaffolds within the dermal matrix. While essential for clearing damaged structural fibers, persistent or altered MMP9 activity can disrupt the delicate balance between matrix breakdown and synthesis. Because the R279Q variant changes the enzyme's catalytic properties, it can influence how efficiently collagen and elastin fibers are degraded during periods of cellular stress or tissue regeneration.
Research Associations: UV Exposure and Beyond
Scientific investigations have linked the MMP9 rs17576 variant to differences in extracellular matrix maintenance, particularly following UV-induced photodamage. Cellular and small observational studies indicate that altered enzyme activity may influence solar elastosis—a process marked by the accumulation of disorganized, damaged elastic tissue in skin exposed to chronic sunlight. Beyond dermatological traits, exploratory candidate-gene studies have evaluated rs17576 in relation to vascular remodeling, carotid plaque stability, and coronary artery disease outcomes. However, the overall strength of clinical evidence for rs17576 remains limited. Many candidate-gene findings have produced mixed or ancestry-specific results that fail to replicate reliably in large-scale, unbiased genome-wide association studies (GWAS). In cardiovascular and inflammatory contexts, observed associations frequently vary across distinct ancestral cohorts, suggesting that rs17576 exerts only small, context-dependent effects alongside other lifestyle and environmental modifiers.
Understanding Population Diversity and Frequencies
The alleles of rs17576 represent common human genetic variation observed throughout the world. Large population databases, such as the Genome Aggregation Database (gnomAD), show that the minor allele is widely distributed across diverse ancestral groups. Specifically, the G allele occurs at an estimated frequency of approximately 15% to 25% among individuals of European and Asian ancestry, with frequencies fluctuating across distinct geographic cohorts and sub-populations. Because neither allele is exceedingly rare, both homozygous and heterozygous genotypes are frequently encountered in standard genotyping tests. High population prevalence typically indicates that an allele is well tolerated and not subject to strong negative evolutionary selection. Consequently, the presence of either allele represents standard genomic diversity rather than a rare pathogenic mutation, and individual genotypes must always be interpreted in the context of broader demographic and environmental factors.
Applying This Information Wisely
Understanding your rs17576 genotype provides an intriguing window into the biology of extracellular matrix regulation, but it carries clear practical limitations. Genotype data for this variant cannot diagnose any medical condition, predict specific cardiovascular events, or quantify personal skin aging rates. Complex physiological traits, from vascular health to solar elastosis, are shaped by dozens of interacting genetic loci together with lifestyle choices, sun protection habits, dietary patterns, and cumulative lifetime UV exposure. Routine health habits—such as applying broad-spectrum sunscreen, avoiding tobacco, and following evidence-based cardiovascular guidelines—have a far greater documented impact on tissue health than any single MMP9 variant. Readers should never alter medical therapies, start unverified supplements, or modify prescription drug regimens based on this genetic marker, and any questions regarding cardiovascular health or skin care should be discussed directly with a qualified healthcare professional.
How common is this variant?
The minor G allele has an estimated frequency of approximately 0.15 to 0.25 across European and Asian populations in gnomAD. Due to these moderate frequencies, all three genotypes (AA, AG, and GG) are common in general population cohorts.
Frequently asked questions
Does the MMP9 rs17576 variant cause skin damage or wrinkles?
No single variant causes skin wrinkles or photodamage on its own. While rs17576 alters the activity of the MMP9 enzyme involved in collagen breakdown after UV photo-exposure, visible changes in skin texture are driven primarily by lifetime sun exposure, smoking, age, and overall skincare habits.
Can rs17576 test results be used to diagnose a disease?
No, rs17576 cannot be used as a standalone diagnostic test for any cardiovascular, inflammatory, or dermatological disorder. The research evidence linking this variant to clinical outcomes is classified as limited and exploratory, reflecting minor statistical associations rather than clear medical causation.
What is the difference between the R279Q notation and rs17576?
The rs17576 designation is the dbSNP reference identifier for the specific location in the DNA sequence on chromosome 20. In contrast, R279Q describes the corresponding protein change, indicating that the amino acid arginine (R) at position 279 is replaced by glutamine (Q).
Should I change my sun care routine based on my MMP9 genotype?
There is no clinical evidence to support tailoring sun protection strategies based on your rs17576 genotype. Dermatological guidelines consistently recommend broad-spectrum sunscreen, protective clothing, and shade for everyone, regardless of genetic background.
Sources & further reading
Educational information only, last refreshed 9/12/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs17576?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MMP9
Functional promoter variant (-1562C>T) in MMP9 affecting transcriptional activity and extracellular matrix remodeling.
Functional promoter variant (-1562C>T) in matrix metallopeptidase 9 altering promoter activity and gelatinase release.
Missense variant in MMP-9 (R279Q) altering gelatinase activity, impacting matrix degradation and structural dermal photo-aging.
This SNP is associated with matrix metalloproteinase activity and cardiovascular disease risk.